TrialCell reports. Medicine2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer.
Carsten Denkert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled ittrialcites it